Neuren Pharmaceuticals Ltd (NEU.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,642 | 20,824 | 24,336 | 10,233 | 14,949 |
| Receivables | 34 | 963 | 1,618 | 130 | 105 |
| TOTAL | $16,676 | $21,787 | $25,997 | $10,482 | $15,140 |
| Non-Current Assets | |||||
| PPE Net | 11 | 29 | 23 | 25 | 5 |
| Intangibles | 217 | 290 | 393 | 3,189 | 3,538 |
| TOTAL | $228 | $319 | $416 | $3,215 | $3,543 |
| Total Assets | $16,904 | $22,106 | $26,413 | $13,697 | $18,683 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,771 | 2,755 | 1,849 | 2,122 | 1,677 |
| Other current liabilities | N/A | N/A | N/A | 6 | 7 |
| TOTAL | $2,502 | $3,028 | $2,058 | $2,531 | $2,146 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 221 | 204 | 157 | 45 |
| TOTAL | $0 | $0 | $0 | $13 | $0 |
| Total Liabilities | $2,502 | $3,028 | $2,058 | $2,544 | $2,146 |
| Shareholders' Equity | |||||
| Common Shares | 111,912 | 104,363 | 101,997 | 64,177 | 61,144 |
| Retained earnings | -89,746 | -84,148 | -87,291 | -65,571 | -58,007 |
| Other shareholders' equity | -7,764 | -916 | 9,854 | 7,878 | 6,256 |
| TOTAL | $14,402 | $19,299 | $24,559 | $6,484 | $9,394 |
| Total Liabilities And Equity | $16,904 | $22,327 | $26,617 | $9,028 | $11,540 |